A61K 38/19
Cytokines
Official title: Cytokines; Lymphokines; Interferons
A61K38/19 (Cytokines) appears on 6,171 US grants and 11,022 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,171
- Published applications
- 11,022
- Assignees
- 3,468
- Inventors
- 16,049
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 6 | 0 |
| 1985 | 6 | 0 |
| 1986 | 5 | 0 |
| 1987 | 11 | 0 |
| 1988 | 13 | 0 |
| 1989 | 34 | 0 |
| 1990 | 23 | 0 |
| 1991 | 22 | 0 |
| 1992 | 45 | 0 |
| 1993 | 66 | 0 |
| 1994 | 44 | 0 |
| 1995 | 33 | 0 |
| 1996 | 46 | 0 |
| 1997 | 82 | 0 |
| 1998 | 116 | 0 |
| 1999 | 107 | 0 |
| 2000 | 103 | 0 |
| 2001 | 95 | 50 |
| 2002 | 113 | 217 |
| 2003 | 90 | 298 |
| 2004 | 79 | 303 |
| 2005 | 85 | 375 |
| 2006 | 100 | 337 |
| 2007 | 86 | 420 |
| 2008 | 123 | 341 |
| 2009 | 141 | 399 |
| 2010 | 174 | 412 |
| 2011 | 160 | 400 |
| 2012 | 218 | 372 |
| 2013 | 224 | 454 |
| 2014 | 275 | 542 |
| 2015 | 308 | 508 |
| 2016 | 323 | 572 |
| 2017 | 335 | 471 |
| 2018 | 292 | 487 |
| 2019 | 335 | 578 |
| 2020 | 318 | 507 |
| 2021 | 316 | 604 |
| 2022 | 301 | 612 |
| 2023 | 217 | 536 |
| 2024 | 250 | 485 |
| 2025 | 277 | 433 |
| 2026 | 169 | 309 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of reducing neuroinflammation6 Oct 2026US 12,751,994 B2ImmunityBio, Inc.
- Methods and materials for ameliorating creatine deficiency disorders6 Oct 2026US 12,751,995 B2The Regents of the University of California
- Application of TFF2 protein and IFN-κ protein combination in treatment of a novel coronavirus infection6 Oct 2026US 12,751,996 B2Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Method of treating SCLC and managing neutropenia29 Sep 2026US 12,746,240 B2Pharma Mar, S. A.
- Application of PEG-interferon and protooncogene product targeting inhibitor in synergistic inhibition of tumors22 Sep 2026US 12,741,012 B2Shanghai Institute of Biological Products Co., Ltd.
- Novel conjugate of immune-stimulating il-2 analog and preparation method thereof8 Oct 2026US 2026/0306646 A1Hanmi Pharm. Co., Ltd.
- Targeted lipid nanoparticles for treating central nervous system injuries8 Oct 2026US 2026/0306665 A1Wisconsin Alumni Research Foundation
- A cytokine-like propeptide gene therapy platform8 Oct 2026US 2026/0308217 A1
- Histamine receptor agonists for cancer therapy in cancer patients unresponsive to cancer immunotherapy and with elevated myeloid derived suppressor cells1 Oct 2026US 2026/0294873 A1TSP Therapeutics Inc.
- Methods for stem cell transplantation1 Oct 2026US 2026/0294975 A1The UAB Research Foundation
Most cited
By later US patents
- Retrograde tissue splitter and method1,605US 5,449,355 AValleylab, Inc. · 1995
- Retrograde tissue splitter and method1,585US 5,797,906 AValleylab, Inc. · 1998
- Gene therapy759US 5,399,346 AThe United States of America as represented by the Department of Health and Human Services · 1995
- Handheld electromechanical surgical system627US 10,932,784 B2Covidien LP · 2021
- Solubilization of proteins for pharmaceutical compositions using polymer conjugation538US 4,766,106 ACetus Corporation · 1988